Reuters logo
BRIEF-Arena Pharmaceuticals reports Q1 loss per share $0.09
May 9, 2017 / 8:53 PM / 5 months ago

BRIEF-Arena Pharmaceuticals reports Q1 loss per share $0.09

May 9 (Reuters) - Arena Pharmaceuticals Inc

* Arena Pharmaceuticals provides corporate update and reports first quarter 2017 financial results

* Q1 loss per share $0.09

* Q1 revenue $6.6 million versus I/B/E/S view $8.1 million

* Q1 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S

* Arena Pharmaceuticals Inc says Ralinepag phase 2 study results expected in July Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below